Stigma, seizure frequency and quality of life: The impact of epilepsy in late adulthood  by McLaughlin, Deirdre P. et al.
Seizure (2008) 17, 281—287
www.elsevier.com/locate/yseizStigma, seizure frequency and quality of life:
The impact of epilepsy in late adulthood
Deirdre P. McLaughlin a,*, Nancy A. Pachana b, Ken Mcfarland ba School of Population Health, University of Queensland, Herston, Queensland 4006, Australia
b School of Psychology, University of Queensland, St Lucia, Queensland 4072, Australia
Received 22 June 2007; received in revised form 16 August 2007; accepted 6 September 2007
KEYWORDS
Older adults;
QOLIE-31;
WPSI;
Stigma;
Seizure frequency
Summary Epilepsy is one of the most common neurological disorders of late
adulthood, yet little research has examined the impact of epilepsy on the quality
of life of older people. Current measures of health-related quality of life (HRQOL)
have been developed and used almost exclusively in adults under the age of 65. The
issues, which affect HRQOL in younger adults, may differ from those which affect
older adults who may have age-related physical limitations and multiple co-morbid-
ities. This study sought to explore the HRQOL and psychosocial function of a com-
munity dwelling sample of 64 older adults with epilepsy compared with a similar, age-
matched control group. An additional objective of the study was to examine the
impact of perceived stigma and seizure frequency on HRQOL and psychosocial well-
being. Results indicated that HRQOL and psychosocial functioning in the epilepsy
group was significantly impaired relative to normal controls. A greater perception of
stigma and more frequent seizures was also strongly related to poor quality of life and
reduced psychosocial function. Although more than two thirds of the sample had
seizure frequency of less than one per year, it was apparent that even infrequent
seizures had the facility to impair HRQOL, suggesting that in older adults, the
apprehension induced by even the possibility of a seizure may be sufficient to reduce
HRQOL. The results have implications for the clinical management of epilepsy and
suggest the need for further research in older populations.
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Despite a growing appreciation of the importance
of research intoconditionswhicheffect olderpeople,
only sporadic empirical investigations have been con-
ducted on any aspect of epilepsy in this age group and
most of these have focussed on pharmaceutical and
medical implications,1—4 with few reporting on the. Published by Elsevier Ltd. All rights reserved.
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in the life of older adults.5,6 Most authors agree that
the impact of epilepsy is substantial and younger
adults with epilepsy have reported health-related
quality of life (HRQOL) which is significantly poorer
than normal controls7,8 and comparable with other
chronic conditions.9 A comprehensive review of stu-
dies which included older people and HRQOL mea-
sures was conducted by Martin et al.6 who concluded
that despite growing appreciation of the importance
of HRQOL issues in themanagement of epilepsy, little
empirical evidence exists to guide clinicians in treat-
ing older patients.
Most common measures of HRQOL in epilepsy
populations, such as the QOLIE-3110 and the
Washington Psychosocial Seizure Inventory (WPSI),11
have been developed, tested and used almost exclu-
sively in adults under the age of 65.12,13 The issues
which most affect HRQOL in younger adults may
differ from those which effect older adults, who
may have multiple medical problems and age-
related physical limitations. The presence of epi-
lepsy in later life also has important psychosocial
implications: increased dependency and conse-
quent feelings of helplessness, fear of loss of con-
trol, stigmatisation and loss of independence
including transportation problems all contribute
to a reduction in HRQOL.14
Seizures have been shown to adversely affect
HRQOL through the stigma that is associated with
them,15—18 with frequent seizures associated with
poorer HRQOL.19—25 Epilepsy has often been
regarded as one of the most stigmatising medical
impairments26 and the effect of this stigma upon
people with epilepsy, particularly those whose atti-
tudes to epilepsy were formed during the early
1950s and 1960s, is yet to be quantified.
This study examined the relationships among
health-related quality of life, psychosocial adjust-
ment, perceptions of stigma and seizure frequency
among a population of older adults. Aims of the
study were to measure HRQOL and psychosocial
adjustment among older, community dwelling epi-
lepsy sufferers and compare this with a healthy,
age-matched control group. An additional objec-
tive of this study was to establish the applicability
of the WPSI and the QOLIE-31 for use with older
adults with epilepsy. In line with current literature,
compared to healthy controls, older people with
epilepsy should demonstrate impaired HRQOL and
psychosocial functioning. In addition, reduced
HRQOL in older people with epilepsy should be
associated with greater perceptions of stigma and
more frequent seizures. There are many age-
related changes that can affect HRQOL, such as
functional limitations, increased co-morbidities,particularly in medical conditions, and changing
life circumstances. Although there is a paucity of
data on HRQOL in older patients with epilepsy, prior
cross-sectional studies of HRQOL in older popula-
tions with a chronic illness have consistently com-
pared results with an age-matched healthy control
group.27—29 In younger epilepsy populations, results
using measures of HRQOL, in particular the QOLIE-
31, have been compared with age-matched control
groups.7,8
Therefore, the hypotheses to be tested are that
older adults with epilepsy will demonstrate
impaired psychosocial functioning and reduced
HRQOL compared with healthy, age-matched con-
trols, and greater perceived stigma and more fre-
quent seizures will be associated with reduced
HRQOL in older people with epilepsy.Methods
Participants and procedure
Epilepsy group. Participants were 64 community
dwelling older adults (28 male, 36 female) with a
confirmed diagnosis of epilepsy. All participants
with epilepsy were under the care of a medical
practitioner at the time of interview and all parti-
cipants had experienced formal testing to confirm
the diagnosis of epilepsy, either by EEG, MRI or CT
scan. Mean age of the group was 67.59 (S.D. 7.42)
years.
Inclusion in the study required that the person be
aged 60 or older, have a diagnosis of epilepsy from a
medical practitioner, have no intellectual impair-
ment, be English speaking and be able to provide
information on their physical and medical status.
Control group. Participants were 60 people over
the age of 60 years (25 male, 35 female) who were
recruited from the general community. Mean age of
the group was 66.50 (S.D. = 7.65) years.
Inclusion in the study required that the person be
aged 60 or older, have no history of epilepsy or
seizures, nor a history of migraine or febrile con-
vulsions, nor of neurological trauma or infection as
these have been associated with the subsequent
onset of epilepsy.30
Measures
Mini mental state exam (MMSE).31 This instrument is
a simple and quick assessment of cognitive function-
ing and has been extensively used in geriatric popu-
lations. Participants were required to achieve an
MMSE score of 24 or above. A lower score than this
would indicate probable cognitive impairment of
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difficulties completing the research protocol.
Washington Psychosocial Seizure Inventory
(WPSI)11 is a self-rating scale that has been exten-
sively used in adult epileptic populations. The WPSI
contains 132 items and measures psychosocial
adjustment on eight scales, including an overall
assessment of psychosocial functioning. State-
ments require a ‘true’ or ‘false’ response with
higher scores indicating impairments in function-
ing. Higher scores on the WPSI indicate poorer
adjustment. There are four areas of profile eleva-
tion identified which assist in interpreting the psy-
chosocial difficulties being experienced: Area 1–—
no problems; Area 2–—slight difficulties; Area 3–—
definite problems; Area 4–—severe problems. The
WPSI has been extensively validated and proven
reliable: it can distinguish people with epileptic
seizures from normal controls or people with none-
pileptic or pseudoseizures. Interrater reliability has
been reported as r = .94 with a test—retest relia-
bility of r = .85 (58). The WPSI has also shown
acceptable internal consistency with reported
Cronbach’s a of .73 (58). A reliability analysis for
the WPSI was performed for this study with a Cron-
bach’s a coefficient of .82.
Quality of life in epilepsy (QOLIE-31)10 is a 31-
item, self-administered questionnaire specifically
designed to measure quality of life of peopleTable 1 Demographic characteristics of the epilepsy and c
Epilepsy g
Male 28 (44%)
Female 36 (56%)
Mean age 67.59 (S.D
Marital status
Married/DeFacto 32 (50%)
Widowed/divorced 19 (30%)
Single 13 (20%)
Education
Tertiary 19 (30%)
High school 22 (34%)
Primary school 17 (27%)
Trade or other qualification 6 (9%)
Employment
Full-time 12 (19%)
Part-time 3 (5%)
Home duties 14 (22%)
Retired 35 (54%)
AE medications
None 2 (3%)
1 33 (52%)
2 22 (34%)
3 7 (11%)with epilepsy and which was derived from the
QOLIE-89.13 The QOLIE-31 has seven of the 17
QOLIE-89 subscales. Responses are summed to
supply subscale scores and a total score, with
higher scores indicative of better functioning.
The QOLIE-31 has demonstrated good psycho-
metric properties with internal consistency
reported as Cronbach’s a = .85 and test—retest
reliability of r = .85.10 Reliability analysis of the
QOLIE-31 for this study revealed an excellent
Cronbach’s a of .95.
Stigma scale16 is a 3-item scale adapted from a
measure which was originally designed to assess the
perceived stigma of stroke and revised to make it
appropriate for epilepsy. Respondents are asked to
state whether, because of their epilepsy, they felt
that other people were uncomfortable with them,
treated them as inferior and preferred to avoid
them. It has a scoring system of 0 (no) or 1 (yes)
for each item and the overall score is the sum of
positive responses, with higher scores associated
with a greater sense of stigma. A score of 3 indicates
that the person is severely stigmatised by epilepsy
(0 = no stigma, 1 = mild stigma, 2 = moderate stigma
and 3 = severe stigma). Validity and reliability has
been well established (Cronbach’s a = .72).16,18
Seizure frequency. In accordance with earlier
research,5 participants were asked to categorise
their seizures as occurring (1) more than once perontrol groups
roup (n = 64) Control group (n = 60)
25 (42%)
35 (58%)
. = 7.42) 66.50 (S.D. = 7.65)
50 (83%)
10 (17%)
–—
26 (43%)
18 (30%)
14 (23%)
2 (4%)
14 (23%)
14 (23%)
8 (14%)
24 (40%)
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once per year or (4) none in the past 12 months.Results
All analyses were performed using SPSS version 12
for Windows.32
Demographic characteristics of the groups
There were no significant differences between the
epilepsy group and the control group on age
(t(122) = .808, p = .99) or level of education (x2(3,
N = 124) = 3.65, p = .30). However, the epilepsy
group and the control group differed significantly
on marital status (x2(4, N = 124) = 24.47, p < .001)
and employment (x2(3, N = 124) = 10.84, p < .05).
Most of the epilepsy group were on anti-epileptic
medications. Demographic characteristics of the
combined epilepsy group and the control group
are presented in Table 1.
To test the hypothesis that older people with
epilepsy would demonstrate impaired psychosocial
function and reduced HRQOL comparedwith healthy
controls, a one-way between groups MANOVA was
performed. Scales of the WPSI and QOLIE-31 which
measured seizure-related factors were excludedTable 2 Summary of mean scores (standard deviations) obta
group compared with general epilepsy population scores
Epilepsy (n = 64)
QOLIE31
Overall QOL 52.89 (23.12)
Emotional well-being 52.97 (19.95)
Energy/fatigue 49.30 (17.86)
Cognitive function 53.39 (22.41)
Social function 53.56 (23.90)
Seizure worry 50.55 (33.76)
Medication effects 50.36 (25.34)
WPSI
Family background 3.08 (2.90)b
Emotional adjust 12.28 (6.21)d
Interpersonal adjust 5.59 (4.55)b
Vocational adjust 3.00 (2.71)e
Financial status 2.30 (2.23)b
Psychosocial functioning 17.44 (10.55)b
Adjust to seizures 4.77 (4.32)b
Medical management 2.69 (2.34)b
*p < .01; **p < .001.
a Cramer et al. (1998).
b Slight difficulties.
c Dodrill et al. (1980).
d Definite problems.
e No problems.from the analysis, however, means and standard
deviations are presented for all scales for the epi-
lepsy group in Table 2. This is to allow comparison
with general epilepsy population scores that have
been reported in other studies.10,11
There was a statistically significant difference
between the epilepsy and the control groups on
the combined dependent variables: F(10, 113) =
7.81, p < .001; Wilks’ Lambda = .59; partial
h2 = .41). When the results for the dependent vari-
ables were considered separately, using an adjusted
alpha level of .01 to allow for violations of equality
of variance in a number of variables, there were
statistically significant differences between the
groups on the WPSI scales of emotional adjustment
(F(1, 122) = 9.27, p < .01, partial h2 = .07), voca-
tional adjustment (F(1, 122) = 31.10, p < .001, par-
tial h2 = .20), financial status (F(1, 122) = 10.13,
p < .01, partial h2 = .08) and psychosocial function
(F(1, 122) = 19.00, p < .001, partial h2 = .14) as well
as on all scales of the QOLIE-31: overall QOL (F(1,
122) = 10.08, p < .01, partial h2 = .08), emotional
well-being (F(1, 122) = 16.31, p < .001, partial
h2 = .12), energy/fatigue (F(1, 122) = 17.35, p <
.001, partial h2 = .12), cognitive functioning (F(1,
122) = 17.12, p < .001, partial h2 = .12) and social
functioning (F(1, 122) = 14.82, p < .001, partial
h2 = .11).ined on QOLIE31 and WPSI by epilepsy group and control
Control (n = 60) General epilepsy
population norms
64.73 (17.88) * 67 (18) a
67.45 (19.96) ** 67 (19)
62.50 (17.41) ** 55 (21)
67.98 (16.13) ** 60 (23)
68.20 (17.77) ** 67 (27)
NA 58 (26)
NA 55 (31)
2.80 (2.99) 2.72 (2.39) c
8.15 (8.76) * 14.95 (8.21)
6.37 (5.94) 7.30 (5.49)
.88 (1.17) ** 5.77 (3.59)
1.12 (1.87) * 2.82 (2.41)
9.40 (9.95) ** 22.50 (13.15)
NA 5.91 (4.16)
NA 2.30 (1.79)
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Table 3 Standard multiple regression of age of onset, stigma and seizure frequency as predictors of HRQOL,
measured by QOLIE-31, for epilepsy group (n = 64)
B S.E. B b sr2 Means Standard
deviations
Stigma 7.98 ** 1.49 .50 .21 1.42 1.25
Seizure frequency
>1 per week 30.63 ** 8.73 .33 .09 .05 .21
>1 per month 13.61 * 4.68 .29 .06 .23 .43
>1 per year 12.62 * 4.17 .31 .07 .36 .48
Intercept = 72.53 R2 = .56, adjusted R2 = .54 R = .75 **
**p < .001, *p < .01.An examination of the means indicated that
the epilepsy group had poorer HRQOL and reduced
psychosocial functioning on the above scales when
compared with the control group.
InordertotestthehypothesisthatHRQOLwouldbe
associatedwith increasedperceptions of stigmaand
greaterseizurefrequency,astandardmultipleregres-
sionwasperformedusingtheoverallQOLIE-31scoreas
thecriterionvariable.Theresultsfortheregressionon
HRQOLaredisplayedinTable3;Rforregressiononthe
HRQOLmeasurewassignificantlydifferentfromzero,
F(4,59) = 19.16,p < .001.
In the HRQOL regression, all of the IVs contrib-
uted significantly to prediction of HRQOL, stigma
(sr2 = .21), more than one seizure per week
(sr2 = .09), more than one seizure per month
(sr2 = .06) and more than one seizure per year
(sr2 = .07). Less stigma and lower frequency of sei-
zures uniquely contributed to the overall prediction
of better health-related quality of life. Overall, the
predictors of stigma and seizure frequency together
accounted for 54% of the variability in health-
related quality of life.
SPSS frequencies were used to further analyse
stigma and seizure frequency for the epilepsy group
and these are illustrated in Table 4.Table 4 Summary of seizure frequency and perceived
stigma for epilepsy group
Epilepsy group
(n = 64)
Stigma
None 22 (34.4%)
Mild 12 (18.8%)
Moderate 11 (17.2%)
Severe 19 (29.7%)
Frequency
>1 per week 3 (4.7%)
>1 per month 15 (23.4%)
>1 per year 23 (35.9%)
None in past year 23 (35.9%)Discussion
This study sought to examine the relationships
among health-related quality of life, psychosocial
adjustment, perceptions of stigma and seizure fre-
quency in a population of older adults. The first
hypothesis that older people with epilepsy would
demonstrate impaired psychosocial function and
reduced HRQOL relative to normal controls was
supported. The second hypothesis, which postu-
lated that perceptions of stigma and seizure fre-
quency would be associated with reduced HRQOL in
the epilepsy group, also received strong support.
Older participants with epilepsy in this study
reported a lower HRQOL and reduced psychosocial
functioning compared with healthy controls. In par-
ticular, all scales of the QOLIE-31 exhibited signifi-
cant differences between the epilepsy group and
the control group, indicating that the epilepsy group
had significantly poorer HRQOL than age-matched
controls. Furthermore, the scales of emotional
adjustment, vocational adjustment, financial status
and the summative scale, psychosocial functioning,
on the WPSI were significantly higher in epilepsy
than controls, signifying a reduction in psychosocial
functioning. Although not a focus of this study, the
importance of emotional adjustment as a factor in
quality of life was highlighted by the significantly
poorer psychological well-being reported by the
epilepsy group on both the QOLIE-31 and the WPSI,
relative to the control group. Older people with
epilepsy have been shown to have similar rates of
affective complaints as younger people with epi-
lepsy5 and the results from scales measuring emo-
tional health on both the QOLIE-31 and the WPSI are
consistent with the findings of earlier authors.9 This
is also consistent with research in other populations
which relates depression and poor mental health
with impaired HRQOL.7,10
As this was the first time, to our knowledge, that
the QOLIE-31 and the WPSI have been applied
solely to older people with epilepsy, a comparison
286 D.P. McLaughlin et al.between the results obtained in this study and results
obtained from analyses of younger adults with epi-
lepsy during development of the measures was
made.10,11 Comparison of the QOLIE-31 scores of this
sample of older adults showed lower scores on all
scales compared with that reported by Cramer
et al.,10 with differences ranging from around 6 to
14 points. Thus the older adults with epilepsy in this
study reported lower overall quality of life, poorer
emotional well-being, reduced energy and greater
fatigue, worse cognitive and social function, than a
sample of younger adults with epilepsy. A similar
comparison of psychosocial functioning by WPSI
scores was more equivocal with only family back-
ground exhibiting greater dysfunction in the older
group than in the younger, normative group. All other
scales were lower than those reported by Dodrill
et al.,11 indicating that this older group was less
psychosocially maladjusted than a group of younger
adults with epilepsy. The summative scales of each
measure indicated that impairments in psychosocial
functioning were reflected by reduced quality of life
in older adults with epilepsy. The WPSI has been
previously used extensively as a measure of psycho-
social function in epilepsy, but some debate sur-
rounding its ability to measure dimensions of
health-related quality of life has limited its use in
recent studies.The results of this studywould suggest
that the WPSI is measuring important aspects of
HRQOL in older adults and although beyond the scope
of this study, further assessment of the WPSI, parti-
cularly in older samples, should beundertaken.Over-
all, both the QOLIE-31 and the WPSI demonstrated
excellent reliability in this sample of older adults,
thus providing support for their future use in similar
populations.
The physical effects of ageing may be associated
with the reductions on the energy/fatigue scale
demonstrated by the epilepsy group, however, this
was not apparent with the control group. More likely,
lowered scores are associated with the effects of
medication, whichmay also effect cognitive function
andthus explain variations on these two scales. Social
functioning in the epilepsy group was significantly
impaired compared with the control group, possibly
resulting from a combination of depression, lack of
energy and confusion, and leading to a reduction in
social contacts and increased social isolation. Addi-
tionally, these results may also reflect an increasing
functional dependence in those whose seizures limit
their ability to drive. Social isolation is frequently
associated with epilepsy8 as people are inhibited
from many social contacts and outings through fear
of having a seizure. In earlier studies of younger
adults with a chronic condition, loss of independence
seriously impacted on HRQOL.14Differences between the epilepsy and control
groups on both vocational adjustment and financial
status may reflect the greater number of control
group participants who were in full time or part time
work (46%) compared to the epilepsy group (24%).
The differences in employment between the groups
may be due, at least in part, to the role played by
epilepsy in limiting work opportunities. Obtaining
employment after age 60 can be challenging and the
additional burden imposed by epilepsy, particularly
where seizures are not controlled, may lead to
reduced opportunities and limited employment
options.
In summary, health-related quality of life and
psychosocial functioning were significantly impaired
in this older epilepsy group compared with age-
matched controls and this result is in contrast with
those reported by Baker et al.,5 who noted that
scores on HRQOL measures did not differ between
older and younger adults. Ageing effects multiple
domains and quality of life may be reduced in late
adulthood as individuals come to terms with the
physical, cognitive, affective and social changes
wrought by ageing with a chronic condition.
Stigma was the strongest predictor of impaired
HRQOL in this study’s group of older persons with
epilepsy, accounting for 21% of the variability in
HRQOL. Overall, the majority of older participants
reported feeling stigmatised by their epilepsy, with
a third of them experiencing severe stigma. Com-
pared with the results reported by other authors
who measured stigma in younger participants,16,17
these results suggest that older people experience
stigma associated with epilepsy to a greater extent
than younger adults. This is in contrast to the find-
ings of Jacoby 16 and Baker et al.,5 who reported
that older people were less likely to feel stigmatised
than younger people. A possible explanation for the
current study’s findings may be that these older
participants shared a schema that depicts epilepsy
as a highly stigmatising condition, identifying it with
many historical prejudices and misunderstandings.
Consistent with reports based on younger adults, the
results from this study indicate that stigma is
strongly associated with diminished self-rated
HRQOL.15,17
As hypothesized, seizure frequency was also a
significant predictor of impaired HRQOL, which
accords with prior studies which have linked more
frequent or intractable seizures with poor HRQOL.24
Although seizure frequency in this sample was not
high, with most participants reporting seizure fre-
quency of less than one per year or none in the past
12 months, it is apparent that even infrequent
seizures have the facility to impair HRQOL. This is
consistent with the conclusions of Gilliam24 and
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rate was acceptable because even infrequent sei-
zures placed limitations on activities of daily living.
For the older persons in the current study, the fear
and apprehension raised by the possibility of a
further seizure may be sufficient in itself to limit
activities and consequently reduce HRQOL.
The results of this study should be interpreted
with caution and considerations given to a number
of limitations of methodology which may be identi-
fied. The sample of both epilepsy and non-epilepsy
participants may not be representative of either
older persons with epilepsy or healthy, community
dwelling controls. As is the case in any study calling
for voluntary involvement, sample selection may be
biased. Older persons with epilepsy are not a homo-
geneous group, but have many differing aetiologies,
medication regimes, lifestyles, personalities and
life experiences that may affect study outcomes.
As this was the first study to investigate measures of
psychosocial well-being and HRQOL in an older
group with epilepsy, there is a need for research
to replicate and expand these findings. In particular,
explorations of the perceptions held by older people
about epilepsy may shed more light on the factors
that compromise HRQOL, including the impact of
seizures and the stigma associated with epilepsy in
this population.References
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